← All decks

Dermatology

Lipodystrophies

Built from Dermatology, 5th Edition

What’s inside

14 sections · 122 slides

  1. 01

    What Lipodystrophy Is

    Selective fat loss, its patterns, and why fat loss matters

    • Definition of lipodystrophy
    • Lipoatrophy vs lipodystrophy vs lipohypertrophy
    • Why fat loss causes disease
    • Two axes of classification
    • Distribution of fat loss and fat gain
    • Reading the classification table
    • Lipodystrophy syndromes: quick-reference
    • Lipodystrophy syndromes: quick-reference (continued)

    8 slides

  2. 02

    Pathogenesis

    Why fat cells fail, and how that drives metabolic disease

    • Fat as an endocrine organ
    • Fat cell hormones and metabolic disease
    • A common pathway: fat cells that cannot store fat
    • From fat cell failure to metabolic disease
    • Adiponectin: the protective fat hormone
    • Leptin replacement reverses insulin resistance

    6 slides

  3. 03

    Congenital Generalized Lipodystrophy

    Berardinelli-Seip syndrome: near-total fat loss from birth

    • Congenital generalized lipodystrophy: overview
    • CGL types 1 and 2: enzyme and lipid droplet defects
    • CGL types 3 and 4: caveolae defects
    • Why the four types look different
    • CGL: cadaveric facies and muscular build
    • CGL: anabolic features and metabolic timeline
    • CGL: organ complications and outcome
    • CGL: how the four types differ in severity
    • Features of congenital generalized lipodystrophy
    • Features of congenital generalized lipodystrophy
    • Features of congenital generalized lipodystrophy (continued)
    • Extensive acanthosis nigricans and lipodystrophy in CGL
    • CGL with acanthosis nigricans and clitoromegaly
    • Extensive acanthosis nigricans in CGL

    14 slides

  4. 04

    Familial Partial Lipodystrophy

    Later-onset, limb-predominant inherited fat loss

    • Familial partial lipodystrophy: overview
    • FPLD subtypes by gene
    • FPLD2: the LMNA gene and nuclear lamina
    • LMNA mutations cause a family of diseases
    • FPLD3: the PPARG gene
    • FPLD4 and the rare FPLD5-7 subtypes
    • Familial partial lipodystrophy with mandibuloacral dysplasia
    • FPLD2: what fat loss looks like
    • Metabolic disturbances in FPLD
    • Skin and gynecologic findings in FPLD
    • Clinical features of FPLD with mandibuloacral dysplasia

    11 slides

  5. 05

    Other Genetic Lipodystrophy Syndromes

    Proteasome disease and a childhood panniculitis syndrome

    • Proteasome-associated autoinflammatory syndromes
    • PRAAS: lipodystrophy and pathology
    • Recurrent lipoatrophic panniculitis of children

    3 slides

  6. 06

    Acquired Generalized Lipodystrophy

    Lawrence syndrome: rare, non-genetic, widespread fat loss

    • Acquired generalized lipodystrophy: overview
    • What comes before AGL
    • AGL: three subtypes
    • AGL diagnostic criteria and subtypes
    • Acquired generalized lipodystrophy: diagnostic criteria and subtypes
    • AGL: clinical pattern of fat loss
    • AGL: panniculitis and disease course
    • Panniculitis preceding fat loss in AGL type 1
    • AGL: organ and gynecologic complications
    • AGL: skin findings and associated autoimmune disease

    10 slides

  7. 07

    Acquired Partial Lipodystrophy

    Barraquer-Simons syndrome: face-to-legs fat loss

    • Acquired partial lipodystrophy: overview
    • APL: pattern and timing of fat loss
    • APL: face-to-legs distribution
    • APL: another patient, with Sjogren syndrome
    • APL: how complement drives adipocyte loss
    • Complement-driven fat loss in APL
    • APL: kidney disease and infection risk
    • APL: other autoimmune associations and metabolic risk

    8 slides

  8. 08

    Localized Lipoatrophy

    The most common form: injections, pressure, trauma and panniculitis

    • Localized lipoatrophy: overview
    • Causes of localized lipoatrophy
    • Injected medications that can cause localized lipoatrophy
    • Insulin lipoatrophy
    • Lipoatrophia semicircularis (semicircular lipoatrophy)
    • Semicircular lipoatrophy: clinical course
    • Pressure lipoatrophy from crossing the legs
    • Involutional lipoatrophy
    • Corticosteroid-injection involutional lipoatrophy under the microscope
    • Atrophic connective tissue panniculitis and lupus panniculitis
    • Facial lipoatrophy from lupus panniculitis
    • Annular lipoatrophy
    • Lipodystrophia centrifugalis abdominalis infantilis
    • LCAI: clinical course and outcome
    • LCAI of the face
    • Other rare localized lipoatrophy patterns

    16 slides

  9. 09

    Lipohypertrophy

    When injected drugs cause fat to build up instead of shrink

    • Lipohypertrophy from insulin therapy
    • Other causes of lipohypertrophy
    • Causes of lipohypertrophy

    3 slides

  10. 10

    Pathology

    What lipodystrophy looks like under the microscope

    • General histologic picture
    • Two histologic patterns in acquired lipodystrophy
    • Involutional changes: two histologic subtypes
    • Localized lipodystrophy and LCAI under the microscope

    4 slides

  11. 11

    Differential Diagnosis

    Rare syndromes and conditions that can mimic lipodystrophy

    • Conditions that can mimic lipodystrophy
    • Leprechaunism and SHORT syndrome
    • Progeria-type syndromes, Cockayne syndrome, and AREDYLD
    • Differential diagnosis of partial and localized lipodystrophy
    • Poland syndrome and lipohypoplasia
    • The role of whole-body MRI

    6 slides

  12. 12

    Treatment

    Managing appearance, metabolism, and systemic complications

    • Three goals of lipodystrophy treatment
    • Cosmetic treatment options
    • Managing insulin injection-site lipoatrophy
    • Treating the metabolic derangements
    • Metreleptin: leptin replacement therapy
    • Treatment of acquired partial lipodystrophy
    • Newer drugs for severe high triglycerides

    7 slides

  13. 13

    Acquired Lipodystrophy From Other Causes

    HIV/ART, cancer drugs, POEMS syndrome, and stem cell transplant

    • HIV/ART-associated lipodystrophy: overview
    • Three mechanisms of ART-associated lipoatrophy
    • Mechanisms of ART-associated lipoatrophy in the tissue
    • Mechanisms of ART-associated lipoatrophy in detail
    • Mechanisms of antiretroviral therapy-associated lipoatrophy
    • Who is most at risk
    • Clinical findings in HIV/ART lipodystrophy
    • HIV/ART lipoatrophy of the face
    • HIV/ART lipoatrophy of the cheeks and legs
    • Temporal fat loss in HIV/ART-associated lipodystrophy
    • Drug-specific fat redistribution patterns
    • Metabolic and cardiovascular consequences
    • Immune checkpoint inhibitor-associated lipodystrophy
    • POEMS syndrome and allogeneic stem cell transplant

    14 slides

  14. 14

    Summary

    Key points to take away about lipodystrophy

    • Key points on lipodystrophy
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Dermatology, 5th Edition (2-Volume Set)

    12 slides